￥ 人民币 $ USD € 欧元
简体中文 English 繁体中文
Menu

News

Medical Halo Global Pharmaceutical News_Targeted Drugs_New Anti-Cancer Drugs_Overseas Medical Information_【Medical Halo Global Pharmaceutical】
Is dacomitinib/dacomitinib suitable for I858R mutation No. 21?

2026-02-01 22:25:32

Check Details
Is brigatinib/brigatinib currently covered by medical insurance?

2026-02-01 22:25:32

Check Details
Can Roflumilast-DALIRESP cure COPD?

2026-02-01 22:25:32

Check Details
Is there a difference between ruxolitinib tablets and ruxolitinib ointment?

2026-02-01 22:25:32

Check Details
What diseases is clofazimine mainly used to treat?

2026-02-01 22:25:32

Check Details
Evaluation of the clinical therapeutic effect of gosatuzumab/Todavir

2026-02-01 22:25:32

Check Details
Current sales status of evantumumab in 2025

2026-02-01 22:25:32

Check Details
How to stipulate the usage and dosage standards of enzalutamide/enzalutamide?

2026-02-01 22:25:32

Check Details
Roflumilast tablets (Roflumilast) - How much should DALIRESP take at one time?

2026-02-01 22:25:32

Check Details
Sorafenib/Nexavar Correct Usage and Dosage Guide

2026-02-01 22:25:32

Check Details
Pemetinib/pemetinib’s domestic launch time and purchase method

2026-02-01 22:25:32

Check Details
What is the market price of a box of erdafitinib in 2025?

2026-02-01 22:25:32

Check Details
Category
相关知识